DK603588A - TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION - Google Patents
TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATIONInfo
- Publication number
- DK603588A DK603588A DK603588A DK603588A DK603588A DK 603588 A DK603588 A DK 603588A DK 603588 A DK603588 A DK 603588A DK 603588 A DK603588 A DK 603588A DK 603588 A DK603588 A DK 603588A
- Authority
- DK
- Denmark
- Prior art keywords
- furo
- thieno
- tetrahydro
- pyridine
- medicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873736664 DE3736664A1 (en) | 1987-10-29 | 1987-10-29 | TETRAHYDRO-FURO- AND -THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK603588D0 DK603588D0 (en) | 1988-10-28 |
| DK603588A true DK603588A (en) | 1989-04-30 |
Family
ID=6339349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK603588A DK603588A (en) | 1987-10-29 | 1988-10-28 | TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0314154A3 (en) |
| JP (1) | JPH01157983A (en) |
| KR (1) | KR890006650A (en) |
| AU (1) | AU2443588A (en) |
| CS (1) | CS273193B2 (en) |
| DD (1) | DD283395A5 (en) |
| DE (1) | DE3736664A1 (en) |
| DK (1) | DK603588A (en) |
| FI (1) | FI884947A (en) |
| HU (1) | HU201553B (en) |
| IL (1) | IL88184A0 (en) |
| NO (1) | NO884835L (en) |
| PL (1) | PL275555A1 (en) |
| PT (1) | PT88899B (en) |
| SU (1) | SU1657064A3 (en) |
| YU (1) | YU201288A (en) |
| ZA (1) | ZA888089B (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623810B2 (en) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| US5272148A (en) * | 1992-09-09 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Heteroarenylpiperazines |
| US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| AU2003217747A1 (en) * | 2002-02-26 | 2003-09-09 | North Shore-Long Island Jewish Research Insitute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
| JP2007530586A (en) | 2004-03-25 | 2007-11-01 | ザ ファインスタイン インスティテュート フォー メディカル リサーチ | Nervous hemostasis |
| CN102793972A (en) | 2004-12-27 | 2012-11-28 | 范因斯坦医学研究院 | Treating inflammatory disorders by electrical vagus nerve stimulation |
| US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
| US8391970B2 (en) | 2007-08-27 | 2013-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
| US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
| WO2009146030A1 (en) | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
| ES2452484T3 (en) | 2008-11-18 | 2014-04-01 | Setpoint Medical Corporation | Devices to optimize electrode placement for anti-inflammatory stimulation |
| US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
| US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| EP2440284B1 (en) | 2009-06-09 | 2018-09-12 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
| US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
| WO2014169145A1 (en) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
| EP2515996B1 (en) | 2009-12-23 | 2019-09-18 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
| EP2707094B1 (en) | 2011-05-09 | 2016-02-03 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
| US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
| US11406833B2 (en) | 2015-02-03 | 2022-08-09 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
| US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
| US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
| WO2017127758A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Implantable microstimulators and inductive charging systems |
| EP3405107B1 (en) | 2016-01-20 | 2023-04-12 | Setpoint Medical Corporation | Control of vagal stimulation |
| US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
| WO2019036470A1 (en) | 2017-08-14 | 2019-02-21 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
| US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| WO2021236977A1 (en) | 2020-05-21 | 2021-11-25 | The Feinstein Institutes For Medical Research | Systems and methods for vagus nerve stimulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2315274A1 (en) * | 1975-06-27 | 1977-01-21 | Parcor | NEW DERIVATIVES OF THIENO (2,3-C) PYRIDINE, THEIR PREPARATION AND THEIR APPLICATIONS |
| FR2317303A1 (en) * | 1975-07-09 | 1977-02-04 | Parcor | PROCESS FOR PREPARING TETRAHYDROTHIENO (3,2-C) AND (2,3-C) PYRIDINE DERIVATIVES |
-
1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/en not_active Withdrawn
-
1988
- 1988-10-27 CS CS712688A patent/CS273193B2/en unknown
- 1988-10-27 IL IL88184A patent/IL88184A0/en unknown
- 1988-10-27 YU YU02012/88A patent/YU201288A/en unknown
- 1988-10-27 DD DD88321141A patent/DD283395A5/en not_active IP Right Cessation
- 1988-10-27 FI FI884947A patent/FI884947A/en not_active IP Right Cessation
- 1988-10-28 PL PL27555588A patent/PL275555A1/en unknown
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/en not_active Withdrawn
- 1988-10-28 PT PT88899A patent/PT88899B/en not_active IP Right Cessation
- 1988-10-28 DK DK603588A patent/DK603588A/en not_active Application Discontinuation
- 1988-10-28 HU HU885642A patent/HU201553B/en not_active IP Right Cessation
- 1988-10-28 ZA ZA888089A patent/ZA888089B/en unknown
- 1988-10-28 JP JP63272853A patent/JPH01157983A/en active Pending
- 1988-10-28 NO NO88884835A patent/NO884835L/en unknown
- 1988-10-28 SU SU884356747A patent/SU1657064A3/en active
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT88899B (en) | 1993-01-29 |
| DE3736664A1 (en) | 1989-05-11 |
| FI884947A0 (en) | 1988-10-27 |
| JPH01157983A (en) | 1989-06-21 |
| SU1657064A3 (en) | 1991-06-15 |
| YU201288A (en) | 1990-08-31 |
| DK603588D0 (en) | 1988-10-28 |
| EP0314154A3 (en) | 1990-12-05 |
| DD283395A5 (en) | 1990-10-10 |
| FI884947A (en) | 1989-04-30 |
| CS273193B2 (en) | 1991-03-12 |
| CS712688A2 (en) | 1990-06-13 |
| IL88184A0 (en) | 1989-06-30 |
| NO884835L (en) | 1989-05-02 |
| ZA888089B (en) | 1990-07-25 |
| EP0314154A2 (en) | 1989-05-03 |
| AU2443588A (en) | 1989-07-13 |
| KR890006650A (en) | 1989-06-15 |
| HU201553B (en) | 1990-11-28 |
| PL275555A1 (en) | 1989-05-02 |
| NO884835D0 (en) | 1988-10-28 |
| HUT50824A (en) | 1990-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK603588A (en) | TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION | |
| DK132789D0 (en) | 9-HALOGEN (Z) PROSTAGLAND INGREDIENTS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE | |
| DK584089A (en) | QUINUCLIDINES, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION | |
| DK143588D0 (en) | SUBSTITUTED 9-AMINO-TETRAHYDROACRIDINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS | |
| DK381985D0 (en) | 3-PYRIDYL COMPOUNDS, THEIR PREPARATION AND USE AS A MEDICINE | |
| DK660788D0 (en) | 2,2-DIFLUOROCYCLOPROPYLETHER DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES | |
| DK435588A (en) | ARALKYLAMINOAL COXYPHENYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MENTALS CONTAINING THESE | |
| NO880473L (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES AND THEIR USE AS A MEDICINE. | |
| DK304090D0 (en) | GLYCEROLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATIONS CONTAINING THESE | |
| DK366888D0 (en) | CASTANOSPERMINESTERS AND GYCOSIDES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS | |
| DK619286D0 (en) | PYRIDINE DERIVATIVES AND N-OXIDES THEREOF, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES | |
| DK0427526T3 (en) | Pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DK495984D0 (en) | 1,3-DIHYDRO-6-METHYL-7-HYDROXYFURO- (3,4-C) PYRIDINE DERIVATIVE, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION | |
| DK291088A (en) | TETREHYDROFURANE AND TETRAHYDROTHIOPHENE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND MEDICINALS CONTAINING SUCH DERIVATIVES | |
| DK247787D0 (en) | PYRAZOL (3,4-B) PYRIDINE DERIVATIVES, PROCEDURES AND INTERMEDIATES FOR PREPARING THEREOF AND USING ITS AS HERBICIDE EFFECTS | |
| DK501888D0 (en) | 6-MERCAPTOPURIN DERIVATIVES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS | |
| DK458078A (en) | 4-PHENYLTHIENO- (2,3-C) PIPERIDINES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| DK87787D0 (en) | PYRROLO (3,4-B) PYRIDINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MEDICINALS CONTAINING THEM | |
| DK364589A (en) | PYRIDO (3,4-F) PYRROLO (1,2-B) (1,2,5) -TRIAZEPINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS | |
| DK454588D0 (en) | SUBSTITUTED THIENOIMIDAZOLE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THEREOF AND THEIR USE AS ANTI-MACHINE ACID PROCEDURES | |
| DK132386D0 (en) | 5H-PYRIDO (3 ', 4'.4,5) PYRROLO (3,2-C) PYRIDINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
| DK288685D0 (en) | 4,5,6,7-TETRAHYDRO-FURO- OR 1H-PYRROLO (2,3-C) PYRIDINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND MEDICINALS CONTAINING SUCH DERIVATIVES | |
| DK276690A (en) | Selenium-derived derivatives, methods for their preparation and therapeutic preparations containing these | |
| DK144787A (en) | PYRIDO (4,3-B) (1,6) NAPHTHYRIDINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| DK513588A (en) | THIENO (2,3-B) FURAN-2-SULPHONAMIDE AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |